Viatris Inc
(MIL:1VTRS)
€
12.41
0 (0%)
Market Cap: 14.79 Bil
Enterprise Value: 28.03 Bil
PE Ratio: 0
PB Ratio: 0.79
GF Score: 43/100 Viatris Inc at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Sep 15, 2022 / 03:45PM GMT
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
Well, good day, everybody. Thanks for joining us at the BofA Healthcare Conference. My name is Jason Gerberry. I'm one of the biopharma analysts here at Bank of America. And I'm pleased to be introducing our next company Viatris, and we're joined by the team. We've got Michael Goettler, CEO; Rajiv Malik, President; and Sanjeev Narula, CFO. So gentlemen, thanks so much for joining us.
Michael Goettler
Viatris Inc. - CEO & Executive Director
Thanks, Jason.
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research
I think, Michael, you may have a few prepared remarks first before we jump into Q&A or no?
Michael Goettler
Viatris Inc. - CEO & Executive Director
Not really prepared, but I want to thank you for inviting us to this. And Viatris -- it's almost 2 years old now, like in November will be our second anniversary. And yet, this because of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot